Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Clinical trial NCT02560948 · COMPLETED
Trial details
- NCT number
- NCT02560948
- Sponsor
- BioTech Tools S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-08-01
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.